🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
Primary aldosteronism is the most common cause of secondary hypertension. T...
Status
Recruiting
Location
Department of Nuclear Medicine, First Affiliated Hospital of Fujian Medical University
Start Date
2020-09-01
Trial ID
NCT05188872
Treatments Being Tested
The most common two subtypes of primary aldosteronism (PA ) are aldosterone...
Status
Unknown
Location
the Second Affiliated Hospital of Nanchang University
Start Date
2022-01-01
Trial ID
NCT05186675
Treatments Being Tested
The subjects of this study were patients with essential refractory hyperten...
Status
Recruiting
Location
The Second Affiliated Hospital of Nanchang University
Start Date
2024-08-01
Trial ID
NCT06568640
Treatments Being Tested
Hypertension is a common problem, affecting \>1.1 billion people worldwide....
Status
Not Yet Recruiting
Location
Multiple Locations
Start Date
2025-01-01
Trial ID
NCT06282107
Treatments Being Tested
The aim of this study was to compare the efficacy and safety of adrenalecto...
Status
Recruiting
Location
The First Affiliated Hospital of Xinjiang Medical University
Start Date
2024-08-01
Trial ID
NCT06513585
Treatments Being Tested
In this prospective controlled trial, we aim to determine whether supersele...
Status
Unknown
Location
Yaqiong Zhou
Start Date
2022-04-01
Trial ID
NCT05262660
Resistant hypertension (RH) is usually defined as blood pressure (BP) that ...
Status
Unknown
Location
Multiple Locations
Start Date
2022-10-01
Trial ID
NCT05552300
Treatments Being Tested
Idiopathic hyperaldosteronism (IHA) represents about 65% of primary hyperal...
Status
Recruiting
Location
Fuwai Hospital, National Center for Cardiovascular Disease, Chinese Academy of Medical Sciences and Peking Union Medical College
Start Date
2022-08-01
Trial ID
NCT07328230
Treatments Being Tested
The study aims to assess the effect of superselective adrenal arterial embo...
Status
Recruiting
Location
The Second Affiliated Hospital of Nanchang University
Start Date
2022-10-01
Trial ID
NCT05561361
Treatments Being Tested
The study aims to assess the effect of superselective adrenal arterial embo...
Status
Recruiting
Location
The Second Affiliated Hospital of Nanchang University
Start Date
2022-09-01
Trial ID
NCT05501080
Treatments Being Tested